U.S. Markets closed

Today's Research Reports on Trending Tickers: Sarepta Therapeutics and Sage Therapeutics

NEW YORK, NY / ACCESSWIRE / November 16, 2018 / U.S. equities regained footing on Thursday as oil prices climbed and hopes of a trade agreement between the U.S. and China raised investor’s optimism. The Dow Jones Industrial Average gained 0.83 percent to close at 25,289.27, while the S&P 500 Index jumped 1.06 percent to close at 2,730.20. The Nasdaq Composite Index rose 1.72 percent at 7,259.03.

According to Ray Dalio, founder of Bridgewater Associates, "The world by and large is leveraged long, when there is a downturn, I don't think there's much to protect investors." "Any investor should have a strategic asset allocation mix. In other words, what will be the neutral portfolio in an overall period of time and then figure out where there is alpha. That will distinguish the winners and the losers" referring to the next bear market, he added.

MER Initiates Coverage on:

Sarepta Therapeutics, Inc.
https://marketedgereport.com/report/SRPT/

Sage Therapeutics, Inc.
https://marketedgereport.com/report/SAGE/

Sarepta Therapeutics' stock jumped 6.22% Thursday, to close the day at $118.96. The stock recorded a trading volume of 1,176,191 shares, which was above its three months average volume of 1,136,596 shares. In the last year, Sarepta Therapeutics' shares have traded in a range of 50.68 - 176.50. The share price has gained 134.73% from its 52 week low. The company's shares are currently trading below their 200-day moving average. The stock's 50-day moving average of $134.60 is above its 200-day moving average of $124.75. Shares of Sarepta Therapeutics have fallen roughly 9.43 percent in the past month and are up 113.8 percent year-to-date.

Access MER's Sarepta Therapeutics, Inc. Research Report at:
https://marketedgereport.com/report/SRPT/

On Thursday, shares of Sage Therapeutics recorded a trading volume of 397,847 shares, which was above the three months average volume of 390,183 shares. The stock ended the day 3.54% higher at $111.88. The share price has fallen 42.91% from its 52 week high with a 52 week trading range of 83.56 - 195.97. The company's shares are currently trading below their 200-day moving average. The stock's 50-day moving average of $126.87 is below its 200-day moving average of $148.74. Shares of Sage Therapeutics have fallen roughly 6.96 percent in the past month and are down 32.07 percent year-to-date.

Access MER's Sage Therapeutics, Inc. Research Report at:
https://marketedgereport.com/report/SAGE/

Our Actionable Research on Sarepta Therapeutics, Inc. (NASDAQ : SRPT ) and Sage Therapeutics, Inc. (NASDAQ : SAGE ) can be downloaded free of charge at MarketEdge Report.

MarketEdge Report

We are committed to providing relevant and actionable information for the self-directed investor. Our research is reputed for being a leader in trusted, in-depth analysis vital for informed strategic trading decisions. The nimble investor can leverage our analysis and collective expertise to execute a disciplined approach to stock selection.

MarketEdge has not been compensated; directly or indirectly; for producing or publishing this document.

Disclaimer: This article is written by an independent contributor of MarketEdgeReport.com and Nadia Noorani, a CFA® charter holder, has provided necessary guidance in preparing the document templates. MarketEdgeReport.com is neither a registered broker dealer nor a registered investment advisor. For more information please read our full disclaimer at www.marketedgereport.com/disclaimer.

CONTACT

For any questions, inquiries, or comments reach out to us directly at:

Address:

MarketEdge Report, Unit #901 511 Avenue of the Americas, New York, NY, 10011

Email:

contact@marketedgereport.com

CFA® and Chartered Financial Analyst® are registered trademarks owned by CFA Institute.

SOURCE: MarketEdgeReport.com